0.035
0.0078 (28.68%)
0.0078 (28.68%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zelira Therapeutics Ltd (QB) | ZLDAF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0078 | 28.68% | 0.035 | 0.029 | 0.0381 | 0.033 | 0.0272 | 16:34:08 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.0194 | 0.045 | 0.0256 | 56.89% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 56 | 1,468,732 | $ 0.035347 | $ 51,915 | 222,560 | 0.0179 - 0.079 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:31:44 | 58 | $ 0.033 | USD |
Zelira Therapeutics (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 30.54M | 872.44M | 755.34M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 269.00k | $ - | 0.00% | - | - |
Zelira Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZLDAF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.03 | 0.0381 | 0.0272 | 0.0301968 | 387,795 | 0.005 | 16.67% |
| 1 Month | 0.031 | 0.0438 | 0.027 | 0.0313614 | 224,359 | 0.004 | 12.9% |
| 3 Months | 0.031 | 0.049 | 0.0179 | 0.0303074 | 206,376 | 0.004 | 12.9% |
| 6 Months | 0.046 | 0.059 | 0.0179 | 0.0325836 | 136,374 | -0.011 | -23.91% |
| 1 Year | 0.032 | 0.079 | 0.0179 | 0.0408469 | 125,637 | 0.003 | 9.38% |
| 3 Years | 0.04 | 0.151 | 0.0179 | 0.0669157 | 131,680 | -0.005 | -12.5% |
| 5 Years | 0.04 | 0.151 | 0.0179 | 0.0680419 | 130,890 | -0.005 | -12.5% |
Zelira Therapeutics (QB) Description
| Zelira Therapeutics ("Zelira") is an Australian-based bio-pharmaceutical company that is focused on developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions. The Company has a two-pronged strategy comprising: A human clinical trial programme focused on insomnia, autism and eczema with activities in Australia and Chile. A pre-clinical research programme examining the effect of cannabinoids in breast, brain and pancreatic cancer. It has partnered with the world's leading cancer cannabis researchers at Complutense University Madrid in Spain to conduct certain pre-clinical work testing cannabis-based formulations known to have an effect in humans in order to generate data packs in a form expected by regulators and the pharmaceutical industry. A similar programme is in place with the Australian Telethon Kids Institute targeting paediatric brain cancer and Curtin University targeting pancreatic cancer. |
